Sliding Scale Insulin Use in Nursing Homes Before and After Onset of the COVID-19 Pandemic

January 30, 2024

Research team, including IMPACT Multiple Principal Investigator, Vincent Mor, PhD, described resident demographics, frequency of SSI monotherapy vs combination therapy with another diabetes medication, number of daily capillary blood glucose readings (“fingersticks”), and hypoglycemia (capillary blood glucose <70 mg/dL) and hyperglycemia after first SSI use among all residents with at least 1 administration of SSI documented in the electronic medication administration record. They used interrupted time series analysis (ITS) with segmented linear regression models to examine whether the monthly prevalence of SSI use changed at and after the onset of the COVID-19 pandemic (March 2020).